BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 036131
(499 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 35/99 (35%), Positives = 60/99 (60%), Gaps = 3/99 (3%)
Query: 390 KAKIFTEEEIKTVTNNYAD--MIGCGGSGLVYKGFLSNKTPVAVKKSKI-VDQTKMDEFI 446
+ K F+ E++ ++N+++ ++G GG G VYKG L++ T VAVK+ K Q +F
Sbjct: 24 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 447 NELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
E+ ++S RN++RL G C+ LLVY ++ NG++
Sbjct: 84 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 35/100 (35%), Positives = 61/100 (61%), Gaps = 5/100 (5%)
Query: 390 KAKIFTEEEIKTVTNNYAD--MIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDE--F 445
+ K F+ E++ ++N+ + ++G GG G VYKG L++ VAVK+ K ++T+ E F
Sbjct: 16 QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLK-EERTQGGELQF 74
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
E+ ++S RN++RL G C+ LLVY ++ NG++
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 13/108 (12%)
Query: 394 FTEEEIKTVTNNY--------ADMIGCGGSGLVYKGFLSNKTPVAVKK-SKIVDQTKMD- 443
F+ E+K VTNN+ + +G GG G+VYKG+++N T VAVKK + +VD T +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 444 --EFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQI 489
+F E+ V+++ N+V LLG + LVY ++ NG+L +++
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 13/108 (12%)
Query: 394 FTEEEIKTVTNNY--------ADMIGCGGSGLVYKGFLSNKTPVAVKK-SKIVDQTKMD- 443
F+ E+K VTNN+ + +G GG G+VYKG+++N T VAVKK + +VD T +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 444 --EFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQI 489
+F E+ V+++ N+V LLG + LVY ++ NG+L +++
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 115
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/108 (36%), Positives = 64/108 (59%), Gaps = 13/108 (12%)
Query: 394 FTEEEIKTVTNNY--------ADMIGCGGSGLVYKGFLSNKTPVAVKK-SKIVDQTKMD- 443
F+ E+K VTNN+ + +G GG G+VYKG+++N T VAVKK + +VD T +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 444 --EFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQI 489
+F E+ V+++ N+V LLG + LVY ++ NG+L +++
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 39/108 (36%), Positives = 61/108 (56%), Gaps = 13/108 (12%)
Query: 394 FTEEEIKTVTNNY--------ADMIGCGGSGLVYKGFLSNKTPVAVKK-SKIVDQTKMD- 443
F+ E+K VTNN+ + G GG G+VYKG+++N T VAVKK + +VD T +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 444 --EFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQI 489
+F E+ V ++ N+V LLG + LVY + NG+L +++
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL 112
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 13/112 (11%)
Query: 394 FTEEEIKTVTNN---YADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--------KM 442
F + + T+ +N Y IG GG GLV+KG L V KS I+ + K
Sbjct: 8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 443 DEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHKKGN 494
EF E+ ++S +N N+V+L G L P +V EFV G L+ ++ K +
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH 117
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 13/112 (11%)
Query: 394 FTEEEIKTVTNN---YADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--------KM 442
F + + T+ +N Y IG GG GLV+KG L V KS I+ + K
Sbjct: 8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 443 DEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHKKGN 494
EF E+ ++S +N N+V+L G L P +V EFV G L+ ++ K +
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH 117
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 52.0 bits (123), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 13/112 (11%)
Query: 394 FTEEEIKTVTNN---YADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--------KM 442
F + + T+ +N Y IG GG GLV+KG L V KS I+ + K
Sbjct: 8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 443 DEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHKKGN 494
EF E+ ++S +N N+V+L G L P +V EFV G L+ ++ K +
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH 117
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 405 NYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+ IG G GLV+ G+ NK VA+K K ++ D+FI E V+ +++ +V+L
Sbjct: 30 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLY 88
Query: 465 GCCLETQVPL-LVYEFVGNGTLFEQIHKKGNL 495
G CLE Q P+ LV+EF+ +G L + + + L
Sbjct: 89 GVCLE-QAPICLVFEFMEHGCLSDYLRTQRGL 119
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/116 (31%), Positives = 62/116 (53%), Gaps = 13/116 (11%)
Query: 390 KAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD- 443
+ +I E E+K V ++G G G VYKG + K PVA+K K +
Sbjct: 8 QLRILKETELKRVK-----VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 62
Query: 444 EFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHK-KGNLSCE 498
EF++E ++++ ++ ++VRLLG CL + LV + + +G L E +H+ K N+ +
Sbjct: 63 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQ 117
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/116 (31%), Positives = 62/116 (53%), Gaps = 13/116 (11%)
Query: 390 KAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD- 443
+ +I E E+K V ++G G G VYKG + K PVA+K K +
Sbjct: 31 QLRILKETELKRVK-----VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 85
Query: 444 EFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHK-KGNLSCE 498
EF++E ++++ ++ ++VRLLG CL + LV + + +G L E +H+ K N+ +
Sbjct: 86 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQ 140
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 405 NYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+ IG G GLV+ G+ NK VA+K + ++ D FI E V+ +++ +V+L
Sbjct: 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 71
Query: 465 GCCLETQVPL-LVYEFVGNGTLFEQIHKKGNL 495
G CLE Q P+ LV+EF+ +G L + + + L
Sbjct: 72 GVCLE-QAPICLVFEFMEHGCLSDYLRTQRGL 102
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 405 NYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+ IG G GLV+ G+ NK VA+K + ++ D FI E V+ +++ +V+L
Sbjct: 10 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 68
Query: 465 GCCLETQVPL-LVYEFVGNGTLFEQIHKKGNL 495
G CLE Q P+ LV+EF+ +G L + + + L
Sbjct: 69 GVCLE-QAPICLVFEFMEHGCLSDYLRTQRGL 99
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 405 NYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+ IG G GLV+ G+ NK VA+K + ++ D FI E V+ +++ +V+L
Sbjct: 10 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 68
Query: 465 GCCLETQVPL-LVYEFVGNGTLFEQIHKKGNL 495
G CLE Q P+ LV+EF+ +G L + + + L
Sbjct: 69 GVCLE-QAPICLVFEFMEHGCLSDYLRTQRGL 99
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 405 NYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+ IG G GLV+ G+ NK VA+K + ++ D FI E V+ +++ +V+L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 66
Query: 465 GCCLETQVPL-LVYEFVGNGTLFEQIHKKGNL 495
G CLE Q P+ LV+EF+ +G L + + + L
Sbjct: 67 GVCLE-QAPICLVFEFMEHGCLSDYLRTQRGL 97
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 405 NYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+ IG G GLV+ G+ NK VA+K + ++ D FI E V+ +++ +V+L
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 69
Query: 465 GCCLETQVPL-LVYEFVGNGTLFEQIHKKGNL 495
G CLE Q P+ LV EF+ +G L + + + L
Sbjct: 70 GVCLE-QAPICLVTEFMEHGCLSDYLRTQRGL 100
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 381 SKLQGRSSEKAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT 440
S +Q + +K E E+ T + +G G G V+ G+ + T VAVK K Q
Sbjct: 2 SHMQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QG 58
Query: 441 KM--DEFINELVVVSQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
M D F+ E ++ Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 59 SMSPDAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 106
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 86 EPPFYIIIEFMTYGNLLDYLRE 107
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 409 MIGCGGSGLVYKGFLS-----NKTPVAVK--KSKIVDQTKMDEFINELVVVSQINRRNVV 461
+IG G G VYKG L + PVA+K K+ ++ ++D F+ E ++ Q + N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNII 109
Query: 462 RLLGCCLETQVPLLVYEFVGNGTLFEQIHKK 492
RL G + + +++ E++ NG L + + +K
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREK 140
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRE 309
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 81 EPPFYIIIEFMTYGNLLDYLRE 102
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 82 EPPFYIIIEFMTYGNLLDYLRE 103
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 79 EPPFYIIIEFMTYGNLLDYLRE 100
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 85 EPPFYIITEFMTYGNLLDYLRE 106
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 86 EPPFYIITEFMTYGNLLDYLRE 107
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 81 EPPFYIIIEFMTYGNLLDYLRE 102
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRE 348
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 86 EPPFYIITEFMTYGNLLDYLRE 107
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 225 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 284
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 285 EPPFYIITEFMTYGNLLDYLRE 306
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 86 EPPFYIITEFMTYGNLLDYLRE 107
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRE 102
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRE 102
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRE 102
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 83 EPPFYIITEFMTYGNLLDYLRE 104
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 58/114 (50%), Gaps = 13/114 (11%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 11 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 65
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHK-KGNLSCE 498
++E V++ ++ +V RLLG CL + V L++ + + G L + + + K N+ +
Sbjct: 66 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQ 118
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 86 EPPFYIITEFMTYGNLLDYLRE 107
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 83 EPPFYIITEFMTYGNLLDYLRE 104
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 83 EPPFYIITEFMTYGNLLDYLRE 104
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 34 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 94 EPPFYIITEFMTYGNLLDYLRE 115
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRE 102
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 82 EPPFYIITEFMTYGNLLDYLRE 103
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 79 EPPFYIITEFMTYGNLLDYLRE 100
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY+G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 19 LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
++ EF+ G L + + +
Sbjct: 79 EPPFYIITEFMTYGNLLDYLRE 100
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 12 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 66
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 67 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 97
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 13/114 (11%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 10 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHK-KGNLSCE 498
++E V++ ++ +V RLLG CL + V L+ + + G L + + + K N+ +
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQ 117
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 12 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 66
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 67 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 97
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 14 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 68
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 69 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 99
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 12 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 66
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 67 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 97
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 13 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 67
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 68 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 98
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 11 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 65
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 66 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 96
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 10 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 95
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 14 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 68
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 69 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 99
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFL----SNKTPVAVK--KSKIVDQTKMDEFINELV 450
EI+ + +IG G SG V G L PVA+K K+ ++ + D F++E
Sbjct: 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEAS 102
Query: 451 VVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
++ Q + N++RL G ++ ++V E++ NG+L
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 35 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 89
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 90 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 119
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFL----SNKTPVAVK--KSKIVDQTKMDEFINELV 450
EI+ + +IG G SG V G L PVA+K K+ ++ + D F++E
Sbjct: 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEAS 102
Query: 451 VVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
++ Q + N++RL G ++ ++V E++ NG+L
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 12 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 66
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 67 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 96
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 16 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 70
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 71 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 100
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 13 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 67
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 68 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 97
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 12 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 66
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 67 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 96
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 384 QGRSSEKAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM- 442
Q + +K E E+ T + +G G G V+ G+ + T VAVK K Q M
Sbjct: 3 QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS 59
Query: 443 -DEFINELVVVSQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
D F+ E ++ Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 60 PDAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 104
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 384 QGRSSEKAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM- 442
Q + +K E E+ T + +G G G V+ G+ + T VAVK K Q M
Sbjct: 1 QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS 57
Query: 443 -DEFINELVVVSQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
D F+ E ++ Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 58 PDAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 102
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 17 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 71
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 72 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 101
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 13 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 67
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 68 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 97
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 10 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 13 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 67
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 68 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 97
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 10 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 7 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 62 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 91
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 17 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 71
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 72 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 101
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 384 QGRSSEKAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM- 442
Q + +K E E+ T + +G G G V+ G+ + T VAVK K Q M
Sbjct: 1 QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS 57
Query: 443 -DEFINELVVVSQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
D F+ E ++ Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 58 PDAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 102
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 20 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 74
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 75 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 104
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 4 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 58
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 59 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 88
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+K+ + K + E
Sbjct: 10 RILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 43.1 bits (100), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 398 EIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVSQI 455
E+ T + +G G +G V+ G+ + T VAVK K Q M D F+ E ++ Q+
Sbjct: 9 EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQL 65
Query: 456 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
+ +VRL TQ P+ ++ E++ NG+L +
Sbjct: 66 QHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 96
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 408 DMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCC 467
+++G G G+V K K VA+K+ I +++ FI EL +S++N N+V+L G C
Sbjct: 14 EVVGRGAFGVVCKAKWRAKD-VAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
L LV E+ G+L+ +H
Sbjct: 71 LNPVC--LVMEYAEGGSLYNVLH 91
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 48/84 (57%), Gaps = 7/84 (8%)
Query: 408 DMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCC 467
+++G G G+V K K VA+K+ I +++ FI EL +S++N N+V+L G C
Sbjct: 15 EVVGRGAFGVVCKAKWRAKD-VAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 468 LETQVPL-LVYEFVGNGTLFEQIH 490
L P+ LV E+ G+L+ +H
Sbjct: 72 LN---PVCLVMEYAEGGSLYNVLH 92
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 20/90 (22%), Positives = 45/90 (50%), Gaps = 1/90 (1%)
Query: 405 NYADMIGCGGSGLVYKG-FLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRL 463
N + IG G G V++ + + V + + +++EF+ E+ ++ ++ N+V
Sbjct: 40 NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 464 LGCCLETQVPLLVYEFVGNGTLFEQIHKKG 493
+G + +V E++ G+L+ +HK G
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 9/114 (7%)
Query: 381 SKLQGRSSEKAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFLS---------NKTPVAV 431
S LQG E + F++ + + + G G K FL+ +K VAV
Sbjct: 17 SGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV 76
Query: 432 KKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
K K ++ +F E +++ + +++VR G C E + L+V+E++ +G L
Sbjct: 77 KALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 9 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 65
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 66 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 98
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 63
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 64 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 96
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 8 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 64
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 65 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 97
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 63
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 64 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 96
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 20/90 (22%), Positives = 45/90 (50%), Gaps = 1/90 (1%)
Query: 405 NYADMIGCGGSGLVYKG-FLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRL 463
N + IG G G V++ + + V + + +++EF+ E+ ++ ++ N+V
Sbjct: 40 NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 464 LGCCLETQVPLLVYEFVGNGTLFEQIHKKG 493
+G + +V E++ G+L+ +HK G
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 63
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 64 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 96
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 12 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 68
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 69 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 101
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 42.4 bits (98), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDL 114
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 16 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 72
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 73 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 105
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMKHGDL 119
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 31 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 91 VLSLLGICLRSEGSPLVVLPYMKHGDL 117
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 31 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 91 VLSLLGICLRSEGSPLVVLPYMKHGDL 117
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDL 178
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 42.0 bits (97), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMKHGDL 119
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 38 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 98 VLSLLGICLRSEGSPLVVLPYMKHGDL 124
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 32 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 92 VLSLLGICLRSEGSPLVVLPYMKHGDL 118
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 34 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 94 VLSLLGICLRSEGSPLVVLPYMKHGDL 120
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMKHGDL 119
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMKHGDL 119
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 34 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 94 VLSLLGICLRSEGSPLVVLPYMKHGDL 120
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 2 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 58
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 59 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 91
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 52 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDL 138
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 32 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 92 VLSLLGICLRSEGSPLVVLPYMKHGDL 118
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 51 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDL 137
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDL 116
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 6/87 (6%)
Query: 405 NYADMIGCGGSGLVYKGFLSN----KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRN 459
++ ++IG G G VY G L + K AVK ++I D ++ +F+ E +++ + N
Sbjct: 25 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 460 VVRLLGCCLETQ-VPLLVYEFVGNGTL 485
V+ LLG CL ++ PL+V ++ +G L
Sbjct: 85 VLSLLGICLRSEGSPLVVLPYMKHGDL 111
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 42.0 bits (97), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 396 EEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM--DEFINELVVVS 453
E E+ T + +G G G V+ G+ + T VAVK K Q M D F+ E ++
Sbjct: 3 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMK 59
Query: 454 QINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFE 487
Q+ + +VRL TQ P+ ++ E++ NG+L +
Sbjct: 60 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVD 92
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 40/82 (48%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G VY G + K+ D +++EF+ E V+ +I N+V+LLG C
Sbjct: 40 LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 470 TQVPLLVYEFVGNGTLFEQIHK 491
+V E++ G L + + +
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRE 121
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 11/91 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++ G G VYKG K PVA+K+ + K + E
Sbjct: 17 RILKETEFKKIK-----VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 71
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLV 476
++E V++ ++ +V RLLG CL + V L++
Sbjct: 72 LDEAYVMASVDNPHVCRLLGICLTSTVQLIM 102
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++ G G VYKG K PVA+K+ + K + E
Sbjct: 10 RILKETEFKKIK-----VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 65 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 94
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 13/114 (11%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E++ V ++G G G VYKG + K PVA+K + K + E
Sbjct: 12 RILKETELRKVK-----VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI 66
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHK-KGNLSCE 498
++E V++ + V RLLG CL + V LV + + G L + + + +G L +
Sbjct: 67 LDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQ 119
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++ G G VYKG K PVA+K+ + K + E
Sbjct: 17 RILKETEFKKIK-----VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 71
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 72 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 101
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 27 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 87 LLGVVSQGQPTLVIMELMTRGDL 109
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDL 115
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDL 115
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 23 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 83 LLGVVSQGQPTLVIMELMTRGDL 105
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 24 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 84 LLGVVSQGQPTLVIMELMTRGDL 106
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 27 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 87 LLGVVSQGQPTLVIMELMTRGDL 109
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 11/90 (12%)
Query: 392 KIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMD-EF 445
+I E E K + ++G G G VYKG K PVA+ + + K + E
Sbjct: 44 RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEI 98
Query: 446 INELVVVSQINRRNVVRLLGCCLETQVPLL 475
++E V++ ++ +V RLLG CL + V L+
Sbjct: 99 LDEAYVMASVDNPHVCRLLGICLTSTVQLI 128
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/123 (29%), Positives = 56/123 (45%), Gaps = 10/123 (8%)
Query: 377 QQELSKLQG----RSSEKAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-SNKTPVAV 431
QQ L+K G R+ K K E + + IG G G V+ G L ++ T VAV
Sbjct: 89 QQPLTKKSGVVLHRAVPKDKWVLNHEDLVL----GEQIGRGNFGEVFSGRLRADNTLVAV 144
Query: 432 KK-SKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIH 490
K + + +F+ E ++ Q + N+VRL+G C + Q +V E V G +
Sbjct: 145 KSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 204
Query: 491 KKG 493
+G
Sbjct: 205 TEG 207
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/123 (29%), Positives = 56/123 (45%), Gaps = 10/123 (8%)
Query: 377 QQELSKLQG----RSSEKAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-SNKTPVAV 431
QQ L+K G R+ K K E + + IG G G V+ G L ++ T VAV
Sbjct: 89 QQPLTKKSGVVLHRAVPKDKWVLNHEDLVL----GEQIGRGNFGEVFSGRLRADNTLVAV 144
Query: 432 KK-SKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIH 490
K + + +F+ E ++ Q + N+VRL+G C + Q +V E V G +
Sbjct: 145 KSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 204
Query: 491 KKG 493
+G
Sbjct: 205 TEG 207
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 26 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 86 LLGVVSQGQPTLVIMELMTRGDL 108
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 20 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 80 LLGVVSQGQPTLVIMELMTRGDL 102
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 20 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 80 LLGVVSQGQPTLVIMELMTRGDL 102
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 55 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDL 137
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 26 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 86 LLGVVSQGQPTLVIMELMTRGDL 108
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G +T VA+K ++ + EF+NE V+ + N +VVR
Sbjct: 18 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L++ E + G L
Sbjct: 78 LLGVVSQGQPTLVIMELMTRGDL 100
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 18/62 (29%), Positives = 35/62 (56%)
Query: 424 SNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNG 483
+K VAVK K ++ +F E +++ + +++VR G C E + L+V+E++ +G
Sbjct: 40 QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 99
Query: 484 TL 485
L
Sbjct: 100 DL 101
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 18/62 (29%), Positives = 35/62 (56%)
Query: 424 SNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNG 483
+K VAVK K ++ +F E +++ + +++VR G C E + L+V+E++ +G
Sbjct: 46 QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHG 105
Query: 484 TL 485
L
Sbjct: 106 DL 107
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 410 IGCGGSGLVYKGFL---SNKT-PVAVK--KSKIVDQTK-MDEFINELVVVSQINRRNVVR 462
+G G G+V +G S KT VAVK K ++ Q + MD+FI E+ + ++ RN++R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 463 LLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
L G L + +V E G+L +++ K
Sbjct: 80 LYGVVLTPPMK-MVTELAPLGSLLDRLRK 107
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 410 IGCGGSGLVYKGFL---SNKT-PVAVK--KSKIVDQTK-MDEFINELVVVSQINRRNVVR 462
+G G G+V +G S KT VAVK K ++ Q + MD+FI E+ + ++ RN++R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 463 LLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
L G L + +V E G+L +++ K
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRK 113
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 410 IGCGGSGLVYKGFL---SNKT-PVAVK--KSKIVDQTK-MDEFINELVVVSQINRRNVVR 462
+G G G+V +G S KT VAVK K ++ Q + MD+FI E+ + ++ RN++R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 463 LLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
L G L + +V E G+L +++ K
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRK 113
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 7/115 (6%)
Query: 378 QELSKLQGRSSEKAKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIV 437
QE +K++ R + + E E V + IG G G VYKG VAVK K+V
Sbjct: 14 QEKNKIRPRGQRDSSYYWEIEASEVM--LSTRIGSGSFGTVYKGKWHGD--VAVKILKVV 69
Query: 438 DQT--KMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIH 490
D T + F NE+ V+ + N++ +G + + +V ++ +L++ +H
Sbjct: 70 DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLA-IVTQWCEGSSLYKHLH 123
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 410 IGCGGSGLVYKGFL---SNKT-PVAVK--KSKIVDQTK-MDEFINELVVVSQINRRNVVR 462
+G G G+V +G S KT VAVK K ++ Q + MD+FI E+ + ++ RN++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 463 LLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
L G L + +V E G+L +++ K
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRK 103
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G+V G + VA+K K ++ DEFI E V+ ++ +V+L G C +
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 470 TQVPLLVYEFVGNGTLF 486
+ ++ E++ NG L
Sbjct: 82 QRPIFIITEYMANGCLL 98
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 410 IGCGGSGLVYKGFL---SNKT-PVAVK--KSKIVDQTK-MDEFINELVVVSQINRRNVVR 462
+G G G+V +G S KT VAVK K ++ Q + MD+FI E+ + ++ RN++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 463 LLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
L G L + +V E G+L +++ K
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRK 103
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G+V G + VA+K K ++ DEFI E V+ ++ +V+L G C +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 470 TQVPLLVYEFVGNGTLF 486
+ ++ E++ NG L
Sbjct: 91 QRPIFIITEYMANGCLL 107
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 410 IGCGGSGLVYKGFL---SNKT-PVAVK--KSKIVDQTK-MDEFINELVVVSQINRRNVVR 462
+G G G+V +G S KT VAVK K ++ Q + MD+FI E+ + ++ RN++R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 463 LLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
L G L + +V E G+L +++ K
Sbjct: 80 LYGVVLTPPMK-MVTELAPLGSLLDRLRK 107
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G+V G + VA+K K ++ DEFI E V+ ++ +V+L G C +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 470 TQVPLLVYEFVGNGTLF 486
+ ++ E++ NG L
Sbjct: 91 QRPIFIITEYMANGCLL 107
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G+V G + VA+K K ++ DEFI E V+ ++ +V+L G C +
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 470 TQVPLLVYEFVGNGTLF 486
+ ++ E++ NG L
Sbjct: 75 QRPIFIITEYMANGCLL 91
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 410 IGCGGSGLVYKGFL---SNKT-PVAVK--KSKIVDQTK-MDEFINELVVVSQINRRNVVR 462
+G G G+V +G S KT VAVK K ++ Q + MD+FI E+ + ++ RN++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 463 LLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
L G L + +V E G+L +++ K
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRK 103
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G+V G + VA+K K ++ DEFI E V+ ++ +V+L G C +
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 470 TQVPLLVYEFVGNGTLF 486
+ ++ E++ NG L
Sbjct: 76 QRPIFIITEYMANGCLL 92
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G+V G + VA+K K ++ DEFI E V+ ++ +V+L G C +
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 470 TQVPLLVYEFVGNGTLF 486
+ ++ E++ NG L
Sbjct: 76 QRPIFIITEYMANGCLL 92
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G+V G + VA+K K ++ DEFI E V+ ++ +V+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 470 TQVPLLVYEFVGNGTLF 486
+ ++ E++ NG L
Sbjct: 71 QRPIFIITEYMANGCLL 87
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 410 IGCGGSGLVYKG---FLSNKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRLLG 465
+GCG G V +G + VA+K K ++ +E + E ++ Q++ +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 466 CCLETQVPLLVYEFVGNGTL 485
C + + +LV E G G L
Sbjct: 404 VC-QAEALMLVMEMAGGGPL 422
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 38.9 bits (89), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 2/95 (2%)
Query: 398 EIKTVTNNYAD--MIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
+++ TNN+ +IG G G VYKG L + VA+K+ ++EF E+ +S
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 456 NRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIH 490
++V L+G C E +L+Y+++ NG L ++
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 2/95 (2%)
Query: 398 EIKTVTNNYAD--MIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
+++ TNN+ +IG G G VYKG L + VA+K+ ++EF E+ +S
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 456 NRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIH 490
++V L+G C E +L+Y+++ NG L ++
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 38.5 bits (88), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 410 IGCGGSGLVYKG---FLSNKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRLLG 465
+GCG G V +G + VA+K K ++ +E + E ++ Q++ +VRL+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 466 CCLETQVPLLVYEFVGNGTL 485
C + + +LV E G G L
Sbjct: 78 VC-QAEALMLVMEMAGGGPL 96
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 37.7 bits (86), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGF-LSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G SG VY ++ VA+++ + Q K + INE++V+ + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 469 ETQVPLLVYEFVGNGTL 485
+V E++ G+L
Sbjct: 88 VGDELWVVMEYLAGGSL 104
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 37.7 bits (86), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGF-LSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G SG VY ++ VA+++ + Q K + INE++V+ + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 469 ETQVPLLVYEFVGNGTL 485
+V E++ G+L
Sbjct: 88 VGDELWVVMEYLAGGSL 104
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 37.7 bits (86), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGF-LSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G SG VY ++ VA+++ + Q K + INE++V+ + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 469 ETQVPLLVYEFVGNGTL 485
+V E++ G+L
Sbjct: 88 VGDELWVVMEYLAGGSL 104
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 37.7 bits (86), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGF-LSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G SG VY ++ VA+++ + Q K + INE++V+ + N+V L L
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 469 ETQVPLLVYEFVGNGTL 485
+V E++ G+L
Sbjct: 89 VGDELWVVMEYLAGGSL 105
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 37.7 bits (86), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
+IG G G V G L + PVA+K K+ + + +F+ E ++ Q + N++ L
Sbjct: 29 VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 89 EGVVTKSKPVMIVTEYMENGSL 110
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 37.7 bits (86), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 11/88 (12%)
Query: 409 MIGCGGSGLVYKGFLSNK----TPVAVKKSKIVD--QTKMDEFINELVVVSQINRRNVVR 462
++G G G V +G L + VAVK K+ + Q +++EF++E + + NV+R
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 463 LLGCCLETQV-----PLLVYEFVGNGTL 485
LLG C+E P+++ F+ G L
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDL 128
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLVYKGF-LSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G SG VY ++ VA+++ + Q K + INE++V+ + N+V L L
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 469 ETQVPLLVYEFVGNGTL 485
+V E++ G+L
Sbjct: 89 VGDELWVVMEYLAGGSL 105
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 29/109 (26%), Positives = 56/109 (51%), Gaps = 16/109 (14%)
Query: 391 AKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMDEF 445
A+IF E E++ + ++G G G V+KG S K PV +K I D++ F
Sbjct: 25 ARIFKETELRKLK-----VLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSF 77
Query: 446 ---INELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
+ ++ + ++ ++VRLLG C + + LV +++ G+L + + +
Sbjct: 78 QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQ 125
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 6/91 (6%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQIN 456
E IK V +G G G V+ G+ +N T VAVK K + F+ E ++ +
Sbjct: 12 ESIKLVKK-----LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQ 65
Query: 457 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFE 487
+VRL + + ++ EF+ G+L +
Sbjct: 66 HDKLVRLYAVVTKEEPIYIITEFMAKGSLLD 96
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 37.4 bits (85), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 29/109 (26%), Positives = 56/109 (51%), Gaps = 16/109 (14%)
Query: 391 AKIFTEEEIKTVTNNYADMIGCGGSGLVYKGFL-----SNKTPVAVKKSKIVDQTKMDEF 445
A+IF E E++ + ++G G G V+KG S K PV +K I D++ F
Sbjct: 7 ARIFKETELRKLK-----VLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSF 59
Query: 446 ---INELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
+ ++ + ++ ++VRLLG C + + LV +++ G+L + + +
Sbjct: 60 QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQ 107
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 37.0 bits (84), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G + +T VAVK ++ + EF+NE V+ +VVR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L+V E + +G L
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDL 107
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 37.0 bits (84), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G + +T VAVK ++ + EF+NE V+ +VVR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L+V E + +G L
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDL 107
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G + +T VAVK ++ + EF+NE V+ +VVR
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L+V E + +G L
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDL 106
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G + +T VAVK ++ + EF+NE V+ +VVR
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L+V E + +G L
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDL 104
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G + +T VAVK ++ + EF+NE V+ +VVR
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L+V E + +G L
Sbjct: 86 LLGVVSKGQPTLVVMELMAHGDL 108
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G + +T VAVK ++ + EF+NE V+ +VVR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L+V E + +G L
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDL 107
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 37.0 bits (84), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G + +T VAVK ++ + EF+NE V+ +VVR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L+V E + +G L
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDL 107
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 37.0 bits (84), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)
Query: 410 IGCGGSGLVYKGFLSN------KTPVAVKK-SKIVDQTKMDEFINELVVVSQINRRNVVR 462
+G G G+VY+G + +T VAVK ++ + EF+NE V+ +VVR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 463 LLGCCLETQVPLLVYEFVGNGTL 485
LLG + Q L+V E + +G L
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDL 107
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 36.2 bits (82), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSL 133
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 36.2 bits (82), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 50 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSL 131
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 36.2 bits (82), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSL 133
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 36.2 bits (82), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSL 133
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 36.2 bits (82), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSL 133
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 36.2 bits (82), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSL 133
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 36.2 bits (82), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSL 133
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 36.2 bits (82), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 23/94 (24%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVV 451
+E+ + ++G G G V G L + VA+K K+ + + +F+ E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 452 VSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
+ Q + N++RL G +++ ++V E++ NG+L
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 36.2 bits (82), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 6/87 (6%)
Query: 410 IGCGGSGLVYKG-FLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G G V G + NK V K+ Q F+ E V++Q+ N+V+LLG +
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 469 ETQVPL-LVYEFVGNGTLFEQIHKKGN 494
E + L +V E++ G+L + + +G
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGR 283
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 35.8 bits (81), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 23 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 83 EGVVTKSKPVMIVTEYMENGSL 104
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 35.8 bits (81), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 6/87 (6%)
Query: 410 IGCGGSGLVYKG-FLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G G V G + NK V K+ Q F+ E V++Q+ N+V+LLG +
Sbjct: 29 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 469 ETQVPL-LVYEFVGNGTLFEQIHKKGN 494
E + L +V E++ G+L + + +G
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR 111
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 35.8 bits (81), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 37/78 (47%), Gaps = 1/78 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G V+ G+ +N T VAVK K + F+ E ++ + +VRL
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 470 TQVPLLVYEFVGNGTLFE 487
+ ++ E++ G+L +
Sbjct: 80 EEPIYIITEYMAKGSLLD 97
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 35.8 bits (81), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 6/87 (6%)
Query: 410 IGCGGSGLVYKG-FLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G G V G + NK V K+ Q F+ E V++Q+ N+V+LLG +
Sbjct: 20 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 469 ETQVPL-LVYEFVGNGTLFEQIHKKGN 494
E + L +V E++ G+L + + +G
Sbjct: 76 EEKGGLYIVTEYMAKGSLVDYLRSRGR 102
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 35.8 bits (81), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 6/87 (6%)
Query: 410 IGCGGSGLVYKG-FLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G G V G + NK V K+ Q F+ E V++Q+ N+V+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 469 ETQVPL-LVYEFVGNGTLFEQIHKKGN 494
E + L +V E++ G+L + + +G
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGR 96
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 35.8 bits (81), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 40 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E++ NG+L
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSL 121
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 35.8 bits (81), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFLSNKTP------VAVKKSKIVDQTKM-DEFINEL 449
+EI + + +G G VYKG L P VA+K K + + +EF +E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 450 VVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE 487
++ +++ NVV LLG + Q +++ + +G L E
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 101
>pdb|3P5B|L Chain L, The Structure Of The LdlrPCSK9 COMPLEX REVEALS THE
RECEPTOR IN AN Extended Conformation
Length = 400
Score = 35.4 bits (80), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 20 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 60
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 35.4 bits (80), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFLSNKTP------VAVKKSKIVDQTKM-DEFINEL 449
+EI + + +G G VYKG L P VA+K K + + +EF +E
Sbjct: 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 450 VVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE 487
++ +++ NVV LLG + Q +++ + +G L E
Sbjct: 81 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 118
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 35.4 bits (80), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFLSNKTP------VAVKKSKI-VDQTKMDEFINEL 449
+EI ++IG G G V +G L K P VA+K K + + EF++E
Sbjct: 11 KEIDVSYVKIEEVIGAGEFGEVCRGRL--KAPGKKESCVAIKTLKGGYTERQRREFLSEA 68
Query: 450 VVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
++ Q N++RL G + +++ EF+ NG L
Sbjct: 69 SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 35.4 bits (80), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFLSNKTP------VAVKKSKI-VDQTKMDEFINEL 449
+EI ++IG G G V +G L K P VA+K K + + EF++E
Sbjct: 9 KEIDVSYVKIEEVIGAGEFGEVCRGRL--KAPGKKESCVAIKTLKGGYTERQRREFLSEA 66
Query: 450 VVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
++ Q N++RL G + +++ EF+ NG L
Sbjct: 67 SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 102
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 35.4 bits (80), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 1/85 (1%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLE 469
+G G G+V G + VAVK K ++ DEF E + +++ +V+ G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 470 TQVPLLVYEFVGNGTLFEQIHKKGN 494
+V E++ NG L + G
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGK 99
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 35.4 bits (80), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 400 KTVTNNYADMIGCGGSGLVYKG----FLSNKTPVAVKK-SKIVDQTKMDEFINELVVVSQ 454
+ V + +IG G G+VY G N+ A+K S+I + +++ F+ E +++
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 455 INRRNVVRLLGCCLETQ-VPLLVYEFVGNGTLFEQI 489
+N NV+ L+G L + +P ++ ++ +G L + I
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
>pdb|3P5C|L Chain L, The Structure Of The LdlrPCSK9 COMPLEX REVEALS THE
RECEPTOR IN AN Extended Conformation
Length = 440
Score = 35.0 bits (79), Expect = 0.086, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 6/78 (7%)
Query: 227 DWEITTIEICEEAKICGLNASCDKPKDNTTTSSGYHCKCNKGYEGNPYLSDGCHDVNECE 286
DW I+ C + N C ++ GY C C G++ C D++EC+
Sbjct: 29 DWSDEPIKECGTNECLDNNGGCSHVCNDLKI--GYECLCPDGFQ--LVAQRRCEDIDECQ 84
Query: 287 DPSLNNCTHICDNIPGSY 304
DP + C+ +C N+ G Y
Sbjct: 85 DP--DTCSQLCVNLEGGY 100
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 35.0 bits (79), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 406 YADMIGCGGSGLVYKGFLSNKTP------VAVKKSKIVDQTKMD-EFINELVVVSQINRR 458
Y IG G G V++ P VAVK K M +F E ++++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 459 NVVRLLGCCLETQVPLLVYEFVGNGTLFE 487
N+V+LLG C + L++E++ G L E
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 35.0 bits (79), Expect = 0.094, Method: Compositional matrix adjust.
Identities = 17/63 (26%), Positives = 37/63 (58%), Gaps = 3/63 (4%)
Query: 404 NNYADM--IGCGGSGLVYKGFLSN-KTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNV 460
+ Y D+ +GCGG+GLV+ ++ VA+KK + D + + E+ ++ +++ N+
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 461 VRL 463
V++
Sbjct: 71 VKV 73
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 35.0 bits (79), Expect = 0.098, Method: Compositional matrix adjust.
Identities = 21/89 (23%), Positives = 44/89 (49%), Gaps = 12/89 (13%)
Query: 409 MIGCGGSGLVYKGFLSN------KTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVR 462
M+G G G V + L K V + K+ I+ + ++EF+ E + + + +V +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 463 LLGCCLETQ------VPLLVYEFVGNGTL 485
L+G L ++ +P+++ F+ +G L
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDL 118
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 34.7 bits (78), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 27/92 (29%), Positives = 40/92 (43%), Gaps = 5/92 (5%)
Query: 398 EIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFI----NELVVVS 453
EI ++IG GG G VY+ F VAVK ++ + + I E + +
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 454 QINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
+ N++ L G CL+ LV EF G L
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPL 93
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 34.7 bits (78), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 409 MIGCGGSGLVYKGFLSNKTP------VAVK--KSKIVDQTKMDEFINELVVVSQINRRNV 460
+IG G G V G L K P VA+K KS ++ + D F++E ++ Q + NV
Sbjct: 40 VIGAGEFGEVCSGHL--KLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNV 96
Query: 461 VRLLGCCLETQVPLLVYEFVGNGTL 485
+ L G ++ +++ EF+ NG+L
Sbjct: 97 IHLEGVVTKSTPVMIITEFMENGSL 121
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 34.7 bits (78), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E + NG+L
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSL 133
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 34.7 bits (78), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 23/94 (24%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVV 451
+E+ + ++G G G V G L + VA+K K+ + + +F+ E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 452 VSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
+ Q + N++RL G +++ ++V E + NG+L
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 34.3 bits (77), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 409 MIGCGGSGLVYKGFLSNKTP------VAVK--KSKIVDQTKMDEFINELVVVSQINRRNV 460
+IG G G V G L K P VA+K KS ++ + D F++E ++ Q + NV
Sbjct: 14 VIGAGEFGEVCSGHL--KLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNV 70
Query: 461 VRLLGCCLETQVPLLVYEFVGNGTL 485
+ L G ++ +++ EF+ NG+L
Sbjct: 71 IHLEGVVTKSTPVMIITEFMENGSL 95
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 34.3 bits (77), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 38/84 (45%), Gaps = 1/84 (1%)
Query: 386 RSSEKAKIFTEE-EIKTVTNNYADMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDE 444
R + + IF +E +I ++IG G G VY G + + + + ++ ++
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKA 75
Query: 445 FINELVVVSQINRRNVVRLLGCCL 468
F E++ Q NVV +G C+
Sbjct: 76 FKREVMAYRQTRHENVVLFMGACM 99
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 34.3 bits (77), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 46/86 (53%), Gaps = 7/86 (8%)
Query: 408 DMIGCGGSGLVYKGFLSNKTPVAVK-KSKIVDQTKM---DEFINELVVVSQINRRNVVRL 463
+++G G G V+K +T +K +KI+ M +E NE+ V++Q++ N+++L
Sbjct: 95 EILGGGRFGQVHK---CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 464 LGCCLETQVPLLVYEFVGNGTLFEQI 489
+LV E+V G LF++I
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRI 177
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 34.3 bits (77), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 43/82 (52%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
++G G G V G L + VA+K K+ + + +F+ E ++ Q + N++RL
Sbjct: 23 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G +++ ++V E + NG+L
Sbjct: 83 EGVVTKSKPVMIVTEXMENGSL 104
>pdb|1Z6C|A Chain A, Solution Structure Of An Egf Pair (Egf34) From Vitamin K-
Dependent Protein S
Length = 87
Score = 34.3 bits (77), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 261 YHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSYT 305
+ C+C +GY N S C D++EC S N C +C N PG YT
Sbjct: 25 FECECPEGYRYN-LKSKSCEDIDEC---SENMCAQLCVNYPGGYT 65
>pdb|3M0C|C Chain C, The X-Ray Crystal Structure Of Pcsk9 In Complex With The
Ldl Receptor
Length = 791
Score = 34.3 bits (77), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 332 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 372
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 33.9 bits (76), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 16/62 (25%), Positives = 32/62 (51%)
Query: 424 SNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNG 483
+K VAVK K +F E +++ + ++V+ G C+E ++V+E++ +G
Sbjct: 41 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 100
Query: 484 TL 485
L
Sbjct: 101 DL 102
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 33.9 bits (76), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 408 DMIGCGGSGLVYKGFLS-NKTPVAVKKSKIVD-QTKMDEFINELVVVSQINRRNVVRLLG 465
++IG G + +V + + K VA+K+ + QT MDE + E+ +SQ + N+V
Sbjct: 16 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 466 CCLETQVPLLVYEFVGNGTLFEQI--------HKKGNL 495
+ LV + + G++ + I HK G L
Sbjct: 76 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 113
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 33.9 bits (76), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 7/82 (8%)
Query: 409 MIGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTKMDEFI--NELVVVSQINRRNVVRL 463
++G G G+V K NK VA+KK D KM + I E+ ++ Q+ N+V L
Sbjct: 32 LVGEGSYGMVMK--CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
L C + + LV+EFV + L
Sbjct: 90 LEVCKKKKRWYLVFEFVDHTIL 111
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 33.9 bits (76), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 26/98 (26%), Positives = 46/98 (46%), Gaps = 10/98 (10%)
Query: 408 DMIGCGGSGLVYKGFLS-NKTPVAVKKSKIVD-QTKMDEFINELVVVSQINRRNVVRLLG 465
++IG G + +V + + K VA+K+ + QT MDE + E+ +SQ + N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 466 CCLETQVPLLVYEFVGNGTLFEQI--------HKKGNL 495
+ LV + + G++ + I HK G L
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 33.9 bits (76), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 438 GIC-EAESWMLVMEMAELGPL 457
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 33.9 bits (76), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 437 GIC-EAESWMLVMEMAELGPL 456
>pdb|1LMJ|A Chain A, Nmr Study Of The Fibrillin-1 Cbegf12-13 Pair Of Ca2+
Binding Epidermal Growth Factor-like Domains
Length = 86
Score = 33.5 bits (75), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 19/51 (37%), Positives = 27/51 (52%), Gaps = 2/51 (3%)
Query: 255 TTTSSGYHCKCNKGYEGNPYLSDGCHDVNECE-DPSLNNCTHICDNIPGSY 304
T + CKC++GYE + C D++EC+ DP L +C N GSY
Sbjct: 19 VNTPGDFECKCDEGYESGFMMMKNCMDIDECQRDPLLCR-GGVCHNTEGSY 68
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 33.5 bits (75), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 410 IGCGGSGLVYKGF-LSNKTPVAVKKSKI---VDQTKMDEFINELVVVSQINRRNVVRLLG 465
IG G VY+ L + PVA+KK +I +D + I E+ ++ Q+N NV++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 466 CCLETQVPLLVYEFVGNGTLFEQI---HKKGNLSCER 499
+E +V E G L I K+ L ER
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
>pdb|1N7D|A Chain A, Extracellular Domain Of The Ldl Receptor
Length = 699
Score = 33.5 bits (75), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 314 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 354
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 33.5 bits (75), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 33 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 93 GIC-EAESWMLVMEMAELGPL 112
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 33.5 bits (75), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 95 GIC-EAESWMLVMEMAELGPL 114
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 33.5 bits (75), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 95 GIC-EAESWMLVMEMAELGPL 114
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 33.5 bits (75), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 19/60 (31%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 427 TPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
T VAVK K +++ + ++E V+ Q+N +V++L G C + LL+ E+ G+L
Sbjct: 54 TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 33.5 bits (75), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 37/78 (47%), Gaps = 1/78 (1%)
Query: 409 MIGCGGSGLVYKGF-LSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCC 467
++G G G+VY G LSN+ +A+K+ D E+ + + +N+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 468 LETQVPLLVYEFVGNGTL 485
E + E V G+L
Sbjct: 89 SENGFIKIFMEQVPGGSL 106
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 33.5 bits (75), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 410 IGCGGSGLV-YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G +G+V S+ VAVKK + Q + + NE+V++ NVV + L
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 469 ETQVPLLVYEFVGNGTLFEQI-HKKGN 494
+V EF+ G L + + H + N
Sbjct: 92 VGDELWVVMEFLEGGALTDIVTHTRMN 118
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 33.5 bits (75), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 19/60 (31%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 427 TPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
T VAVK K +++ + ++E V+ Q+N +V++L G C + LL+ E+ G+L
Sbjct: 54 TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 33.5 bits (75), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 19/60 (31%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 427 TPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 485
T VAVK K +++ + ++E V+ Q+N +V++L G C + LL+ E+ G+L
Sbjct: 54 TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 33.5 bits (75), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 37/78 (47%), Gaps = 1/78 (1%)
Query: 409 MIGCGGSGLVYKGF-LSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCC 467
++G G G+VY G LSN+ +A+K+ D E+ + + +N+V+ LG
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 468 LETQVPLLVYEFVGNGTL 485
E + E V G+L
Sbjct: 75 SENGFIKIFMEQVPGGSL 92
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 33.5 bits (75), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 24/77 (31%), Positives = 36/77 (46%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLV-YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G +G+V S+ VAVKK + Q + + NE+V++ NVV + L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 469 ETQVPLLVYEFVGNGTL 485
+V EF+ G L
Sbjct: 219 VGDELWVVMEFLEGGAL 235
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 33.1 bits (74), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 410 IGCGGSGLV-YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G +G+V S+ VAVKK + Q + + NE+V++ NVV + L
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 469 ETQVPLLVYEFVGNGTLFEQI-HKKGN 494
+V EF+ G L + + H + N
Sbjct: 99 VGDELWVVMEFLEGGALTDIVTHTRMN 125
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 33.1 bits (74), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 410 IGCGGSGLV-YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G +G+V S+ VAVKK + Q + + NE+V++ NVV + L
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 469 ETQVPLLVYEFVGNGTLFEQI-HKKGN 494
+V EF+ G L + + H + N
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMN 114
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 33.1 bits (74), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 410 IGCGGSGLV-YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G +G+V S+ VAVKK + Q + + NE+V++ NVV + L
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 469 ETQVPLLVYEFVGNGTLFEQI-HKKGN 494
+V EF+ G L + + H + N
Sbjct: 97 VGDELWVVMEFLEGGALTDIVTHTRMN 123
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 33.1 bits (74), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 409 MIGCGGSGLVYKGFLS----NKTPVAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRL 463
+IG G G V G L VA+K K+ + + +F+ E ++ Q + NVV L
Sbjct: 50 VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G + ++V EF+ NG L
Sbjct: 110 EGVVTRGKPVMIVIEFMENGAL 131
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 33.1 bits (74), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 79 GIC-EAESWMLVMEMAELGPL 98
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 33.1 bits (74), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 79 GIC-EAESWMLVMEMAELGPL 98
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 33.1 bits (74), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 85 GIC-EAESWMLVMEMAELGPL 104
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 33.1 bits (74), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 24/77 (31%), Positives = 36/77 (46%), Gaps = 1/77 (1%)
Query: 410 IGCGGSGLV-YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCL 468
IG G +G+V S+ VAVKK + Q + + NE+V++ NVV + L
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 469 ETQVPLLVYEFVGNGTL 485
+V EF+ G L
Sbjct: 142 VGDELWVVMEFLEGGAL 158
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 33.1 bits (74), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 13 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 73 GIC-EAESWMLVMEMAELGPL 92
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 33.1 bits (74), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 410 IGCGGSGLVYKGFLS-----NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLL 464
+G G G V KG+ V + K++ D DE + E V+ Q++ +VR++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 465 GCCLETQVPLLVYEFVGNGTL 485
G C E + +LV E G L
Sbjct: 75 GIC-EAESWMLVMEMAELGPL 94
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 32.7 bits (73), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 15/47 (31%), Positives = 26/47 (55%)
Query: 443 DEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQI 489
+E NE+ ++ ++ N+++L + + LV EF G LFEQI
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI 137
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 32.7 bits (73), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 5/98 (5%)
Query: 406 YADMIGCGGSGLVYKGFLSN---KTPVAVKKSK-IVDQTKMDEFINELVVVSQINRR-NV 460
+ D+IG G G V K + + A+K+ K + +F EL V+ ++ N+
Sbjct: 19 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 461 VRLLGCCLETQVPLLVYEFVGNGTLFEQIHKKGNLSCE 498
+ LLG C L E+ +G L + + K L +
Sbjct: 79 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 116
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 32.7 bits (73), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 5/98 (5%)
Query: 406 YADMIGCGGSGLVYKGFLSN---KTPVAVKKSK-IVDQTKMDEFINELVVVSQINRR-NV 460
+ D+IG G G V K + + A+K+ K + +F EL V+ ++ N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 461 VRLLGCCLETQVPLLVYEFVGNGTLFEQIHKKGNLSCE 498
+ LLG C L E+ +G L + + K L +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 32.7 bits (73), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 406 YADMIGCGGSGLVYKGFLSN---KTPVAVKKSK-IVDQTKMDEFINELVVVSQINRR-NV 460
+ D+IG G G V K + + A+K+ K + +F EL V+ ++ N+
Sbjct: 26 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 461 VRLLGCCLETQVPLLVYEFVGNGTLFEQIHK 491
+ LLG C L E+ +G L + + K
Sbjct: 86 INLLGACEHRGYLYLAIEYAPHGNLLDFLRK 116
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 32.0 bits (71), Expect = 0.74, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 409 MIGCGGSGLVYKGFLSNKTP------VAVK--KSKIVDQTKMDEFINELVVVSQINRRNV 460
+IG G G V G L K P VA+K K+ D+ + D F++E ++ Q + N+
Sbjct: 36 VIGVGEFGEVCSGRL--KVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 92
Query: 461 VRLLGCCLETQVPLLVYEFVGNGTL 485
+ L G + + +++ E++ NG+L
Sbjct: 93 IHLEGVVTKCKPVMIITEYMENGSL 117
>pdb|2W2N|E Chain E, Wt Pcsk9-Deltac Bound To Egf-A H306y Mutant Of Ldlr
Length = 107
Score = 32.0 bits (71), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 49 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 89
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 32.0 bits (71), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 409 MIGCGGSGLVYKGFLSNKTP------VAVK--KSKIVDQTKMDEFINELVVVSQINRRNV 460
+IG G G V G L K P VA+K K+ D+ + D F++E ++ Q + N+
Sbjct: 21 VIGVGEFGEVCSGRL--KVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 77
Query: 461 VRLLGCCLETQVPLLVYEFVGNGTL 485
+ L G + + +++ E++ NG+L
Sbjct: 78 IHLEGVVTKCKPVMIITEYMENGSL 102
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 32.0 bits (71), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 11/85 (12%)
Query: 409 MIGCGGSGLVYKGFLSNKTP------VAVK--KSKIVDQTKMDEFINELVVVSQINRRNV 460
+IG G G V G L K P VA+K K+ D+ + D F++E ++ Q + N+
Sbjct: 15 VIGVGEFGEVCSGRL--KVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 71
Query: 461 VRLLGCCLETQVPLLVYEFVGNGTL 485
+ L G + + +++ E++ NG+L
Sbjct: 72 IHLEGVVTKCKPVMIITEYMENGSL 96
>pdb|2W2M|E Chain E, Wt Pcsk9-Deltac Bound To Wt Egf-A Of Ldlr
pdb|2W2O|E Chain E, Pcsk9-deltac D374y Mutant Bound To Wt Egf-a Of Ldlr
pdb|2W2P|E Chain E, Pcsk9-Deltac D374a Mutant Bound To Wt Egf-A Of Ldlr
pdb|2W2Q|E Chain E, Pcsk9-Deltac D374h Mutant Bound To Wt Egf-A Of Ldlr
Length = 107
Score = 32.0 bits (71), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 49 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 89
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 32.0 bits (71), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 12 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 70 DVIHTENKLYLVFEFL 85
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 31.6 bits (70), Expect = 0.93, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 31.6 bits (70), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 31.6 bits (70), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 102 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 160
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 161 NLREYLQAR 169
>pdb|3GCW|E Chain E, Pcsk9:egfa(H306y)
Length = 83
Score = 31.6 bits (70), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 25 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 65
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 31.6 bits (70), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 12 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 70 DVIHTENKLYLVFEFL 85
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 31.6 bits (70), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 31.6 bits (70), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 13 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 71 DVIHTENKLYLVFEFL 86
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 31.6 bits (70), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 44/92 (47%), Gaps = 7/92 (7%)
Query: 406 YADMIGCGGSGLVY--KGFLSNKTPVA--VKKSKIVDQTKMDEFINELVVVSQINRRNVV 461
+ +++G G V+ K L+ K +KKS + ++ NE+ V+ +I N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIV 69
Query: 462 RLLGCCLETQVPLLVYEFVGNGTLFEQIHKKG 493
L T LV + V G LF++I ++G
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERG 101
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 31.6 bits (70), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 31.6 bits (70), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 10 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 68 DVIHTENKLYLVFEFL 83
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 31.6 bits (70), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 13 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 71 DVIHTENKLYLVFEFL 86
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 31.6 bits (70), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 15 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 73 DVIHTENKLYLVFEFL 88
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 31.6 bits (70), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 31.6 bits (70), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 13 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 71 DVIHTENKLYLVFEFL 86
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 31.6 bits (70), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 10 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 68 DVIHTENKLYLVFEFL 83
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 31.6 bits (70), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 18 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 76 DVIHTENKLYLVFEFL 91
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 31.6 bits (70), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 12 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 70 DVIHTENKLYLVFEFL 85
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 53 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 111
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 112 NLREYLQAR 120
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 12 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 70 DVIHTENKLYLVFEFL 85
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 14 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 72 DVIHTENKLYLVFEFL 87
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 14 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 72 DVIHTENKLYLVFEFL 87
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 13 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 71 DVIHTENKLYLVFEFL 86
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 14 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 72 DVIHTENKLYLVFEFL 87
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 10 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 68 DVIHTENKLYLVFEFL 83
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 12 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 70 DVIHTENKLYLVFEFL 85
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 14 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 72 DVIHTENKLYLVFEFL 87
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 18 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 76 DVIHTENKLYLVFEFL 91
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 61 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 120 NLREYLQAR 128
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 61 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 120 NLREYLQAR 128
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 50 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 108
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 109 NLREYLQAR 117
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 61 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 120 NLREYLQAR 128
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 14 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 72 DVIHTENKLYLVFEFL 87
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 10 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 68 DVIHTENKLYLVFEFL 83
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 15 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 73 DVIHTENKLYLVFEFL 88
>pdb|1HZ8|A Chain A, Solution Structure And Backbone Dynamics Of A Concatemer
Of Egf-Homology Modules Of The Human Low Density
Lipoprotein Receptor
pdb|1I0U|A Chain A, Solution Structure And Backbone Dynamics Of A Concatemer
Of Egf-Homology Modules Of The Human Low Density
Lipoprotein Receptor
Length = 82
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 22 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 62
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 54 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 112
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 113 NLREYLQAR 121
>pdb|3BPS|E Chain E, Pcsk9:egf-a Complex
pdb|3GCX|E Chain E, Pcsk9:egfa (Ph 7.4)
Length = 83
Score = 31.6 bits (70), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 25 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 65
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIISLLNV 91
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 46 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 104
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 105 NLREYLQAR 113
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 31.6 bits (70), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 45/99 (45%), Gaps = 10/99 (10%)
Query: 407 ADMIGCGGSGLVYKGFLSNKT----PVAVKKSKIVDQTK---MDEFINELVVVSQINRRN 459
D +G GG VY L+ T VA+K I + K + F E+ SQ++ +N
Sbjct: 16 VDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 460 VVRLLGCCLETQVPLLVYEFVGNGTLFEQIHKKGNLSCE 498
+V ++ E LV E++ TL E I G LS +
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD 111
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 427 TPVAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 483
T VAVK K D T+ D + I+E+ ++ I + +N++ LLG C + ++ E+ G
Sbjct: 61 TKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 484 TLFEQIHKK 492
L E + +
Sbjct: 120 NLREYLQAR 128
>pdb|2JG8|C Chain C, Crystallographic Structure Of Human C1q Globular Heads
Complexed To Phosphatidyl-Serine
pdb|2JG8|F Chain F, Crystallographic Structure Of Human C1q Globular Heads
Complexed To Phosphatidyl-Serine
pdb|2JG9|C Chain C, Crystallographic Structure Of Human C1q Globular Heads
(P1)
pdb|2JG9|F Chain F, Crystallographic Structure Of Human C1q Globular Heads
(P1)
pdb|2WNU|C Chain C, Complex Between C1q Globular Heads And Heparan Sulfate
pdb|2WNU|F Chain F, Complex Between C1q Globular Heads And Heparan Sulfate
pdb|2WNV|C Chain C, Complex Between C1q Globular Heads And Deoxyribose
pdb|2WNV|F Chain F, Complex Between C1q Globular Heads And Deoxyribose
Length = 131
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 13/27 (48%), Positives = 17/27 (62%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFL 423
EE+ N+Y DM+G GS V+ GFL
Sbjct: 101 EEVWLAVNDYYDMVGIQGSDSVFSGFL 127
>pdb|1PK6|C Chain C, Globular Head Of The Complement System Protein C1q
Length = 129
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 13/27 (48%), Positives = 17/27 (62%)
Query: 397 EEIKTVTNNYADMIGCGGSGLVYKGFL 423
EE+ N+Y DM+G GS V+ GFL
Sbjct: 99 EEVWLAVNDYYDMVGIQGSDSVFSGFL 125
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIISLLNV 91
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 90 TKPQLA-IVTQWCEGSSLYHHLH 111
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIISLLNV 91
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 39/85 (45%), Gaps = 11/85 (12%)
Query: 408 DMIGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKMDEFINE--LVVVSQINRRNVVRLLG 465
++IG G G VYKG L + PVAVK ++ FINE + V + N+ R +
Sbjct: 19 ELIGRGRYGAVYKGSLDER-PVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIV 74
Query: 466 CCLETQVP-----LLVYEFVGNGTL 485
LLV E+ NG+L
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSL 99
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 20 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 78 TKPQLA-IVTQWCEGSSLYHHLH 99
>pdb|1HJ7|A Chain A, Nmr Study Of A Pair Of Ldl Receptor Ca2+ Binding Epidermal
Growth Factor-Like Domains, 20 Structures
Length = 80
Score = 31.2 bits (69), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 260 GYHCKCNKGYEGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSY 304
GY C C G++ C D++EC+DP + C+ +C N+ G Y
Sbjct: 22 GYECLCPDGFQ--LVAQRRCEDIDECQDP--DTCSQLCVNLEGGY 62
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 31.2 bits (69), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 6/77 (7%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKI-VDQTKMDEFINELVVVSQINRRNVVRLLG 465
+G G VYKG NKT VA+K+ K+ ++ I E+ ++ ++ N+VRL
Sbjct: 13 LGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 466 CCLETQVPLLVYEFVGN 482
LV+EF+ N
Sbjct: 71 VIHTENKLTLVFEFMDN 87
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 31.2 bits (69), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 79 TKPQLA-IVTQWCEGSSLYHHLH 100
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 36 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 94 TKPQLA-IVTQWCEGSSLYHHLH 115
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 18 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 76 TKPQLA-IVTQWCEGSSLYHHLH 97
>pdb|1LLQ|A Chain A, Crystal Structure Of Malic Enzyme From Ascaris Suum
Complexed With Nicotinamide Adenine Dinucleotide
pdb|1LLQ|B Chain B, Crystal Structure Of Malic Enzyme From Ascaris Suum
Complexed With Nicotinamide Adenine Dinucleotide
pdb|1O0S|A Chain A, Crystal Structure Of Ascaris Suum Malic Enzyme Complexed
With Nadh
pdb|1O0S|B Chain B, Crystal Structure Of Ascaris Suum Malic Enzyme Complexed
With Nadh
Length = 605
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 10/96 (10%)
Query: 212 YLAVGGIPEKF--PVVLDWEITTIEICEEAKICGLNASCDKPKDNTTTSSGYHCKCNKGY 269
Y+A+GG+ K+ PV+LD +++ + GL + KD T + C K Y
Sbjct: 203 YVALGGVQPKWCLPVLLDVGTNNMDLLNDPFYIGLRHKRVRGKDYDTLLDNFMKACTKKY 262
Query: 270 EGNPYLSDGCHDVNECEDPSLNNCTHICDNIPGSYT 305
G + + ED + N + D YT
Sbjct: 263 --------GQKTLIQFEDFANPNAFRLLDKYQDKYT 290
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 79 TKPQLA-IVTQWCEGSSLYHHLH 100
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 102 TKPQLA-IVTQWCEGSSLYHHLH 123
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 102 TKPQLA-IVTQWCEGSSLYHHLH 123
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 74 TKPQLA-IVTQWCEGSSLYHHLH 95
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 43 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 101 TKPQLA-IVTQWCEGSSLYHHLH 122
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
+ Q+ +V ++ +L+ +H
Sbjct: 74 TKPQLA-IVTQWCEGSSLYHHLH 95
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 30.8 bits (68), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
Q+ +V ++ +L+ +H
Sbjct: 90 TAPQLA-IVTQWCEGSSLYHHLH 111
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 20/67 (29%), Positives = 33/67 (49%), Gaps = 1/67 (1%)
Query: 429 VAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQ 488
VAVKK + Q + + NE+V++ + NVV + L +V EF+ G L +
Sbjct: 73 VAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDI 132
Query: 489 I-HKKGN 494
+ H + N
Sbjct: 133 VTHTRMN 139
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 26/105 (24%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 409 MIGCGGSGLVYKGFLS-NKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCC 467
++G G G V K + + A+KK + ++ K+ ++E+++++ +N + VVR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 468 LETQ-------------VPLLVYEFVGNGTLFEQIHKKGNLSCER 499
LE + + E+ NGTL++ IH + NL+ +R
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQR 115
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 30.4 bits (67), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 16/47 (34%), Positives = 24/47 (51%)
Query: 447 NELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHKKG 493
NE+ V+ +I N+V L LV + V G LF++I +KG
Sbjct: 69 NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKG 115
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 30.4 bits (67), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 30.4 bits (67), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 5/83 (6%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQT--KMDEFINELVVVSQINRRNVVRLLGCC 467
IG G G VYKG VAVK + T ++ F NE+ V+ + N++ +G
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 468 LETQVPLLVYEFVGNGTLFEQIH 490
Q+ +V ++ +L+ +H
Sbjct: 74 TAPQLA-IVTQWCEGSSLYHHLH 95
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 30.4 bits (67), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 30.0 bits (66), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 9/73 (12%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKK--SKIVDQTKMDEFINELVVVS 453
TV Y ++ IG G G+V Y L VA+KK +QT ELV++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 454 QINRRNVVRLLGC 466
+N +N++ LL
Sbjct: 79 VVNHKNIIGLLNV 91
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 30.0 bits (66), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 20/66 (30%), Positives = 36/66 (54%), Gaps = 2/66 (3%)
Query: 429 VAVKKSK-IVDQTKMDEFINELVVVSQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGTLF 486
VAVK K D ++ + ++EL +++Q+ + N+V LLG C + L++E+ G L
Sbjct: 78 VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 487 EQIHKK 492
+ K
Sbjct: 138 NYLRSK 143
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 30.0 bits (66), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 29/114 (25%), Positives = 49/114 (42%), Gaps = 11/114 (9%)
Query: 387 SSEKAKIFTEEEIKTVTNNYADM---IGCGGSG----LVYKGFLSNKTPVAVKKSKIVDQ 439
SS + ++ + K N Y + IG G G V KG + + K + D
Sbjct: 8 SSGRENLYFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED- 66
Query: 440 TKMDEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQ-IHKK 492
+D F E+ ++ ++ N++RL + LV E G LFE+ +HK+
Sbjct: 67 --VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR 118
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 30.0 bits (66), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKI--VDQTKMDEFINELVVVSQINRRNVVRLLGCC 467
+G G G+VYK S VA+K+ ++ D+ I E+ ++ +++ N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 468 LETQVPLLVYEFV 480
+ LV+EF+
Sbjct: 89 HSERCLTLVFEFM 101
>pdb|1LP3|A Chain A, The Atomic Structure Of Adeno-Associated Virus (Aav-2), A
Vector For Human Gene Therapy
pdb|3J1S|A Chain A, Structure Of Adeno-Associated Virus-2 In Complex With
Neutralizing Monoclonal Antibody A20
Length = 519
Score = 30.0 bits (66), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 17/43 (39%), Positives = 23/43 (53%)
Query: 360 HMKLKEKFFEQNGGSILQQELSKLQGRSSEKAKIFTEEEIKTV 402
H +EKFF Q+G I ++ S+ EK I EEEI+T
Sbjct: 310 HKDDEEKFFPQSGVLIFGKQGSEKTNVDIEKVMITDEEEIRTT 352
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 30.0 bits (66), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 5/69 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 456 NRRNVVRLL 464
N +N++ LL
Sbjct: 119 NHKNIISLL 127
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 30.0 bits (66), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKI--VDQTKMDEFINELVVVSQINRRNVVRLLGCC 467
+G G G+VYK S VA+K+ ++ D+ I E+ ++ +++ N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 468 LETQVPLLVYEFV 480
+ LV+EF+
Sbjct: 89 HSERCLTLVFEFM 101
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 30.0 bits (66), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 39/76 (51%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 10 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 465 GCCLETQVPLLVYEFV 480
LV+E V
Sbjct: 68 DVIHTENKLYLVFEHV 83
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 29.6 bits (65), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 20/70 (28%), Positives = 30/70 (42%), Gaps = 5/70 (7%)
Query: 425 NKTPVAVKKSKIVDQTKM-----DEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEF 479
KTP +KI++ K+ + E + + N+VRL E LV++
Sbjct: 52 KKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDL 111
Query: 480 VGNGTLFEQI 489
V G LFE I
Sbjct: 112 VTGGELFEDI 121
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 29.6 bits (65), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 119 NHKNIISLLNV 129
>pdb|1DX5|I Chain I, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|J Chain J, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|K Chain K, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|L Chain L, Crystal Structure Of The Thrombin-Thrombomodulin Complex
Length = 118
Score = 29.6 bits (65), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 15/61 (24%)
Query: 246 ASCDKPKDNTTTSSGYHCKCNKGYEGNPYLSDG--CHDVNECEDPSLNNCTHICDNIPGS 303
A CD NT S C+C +GY L DG C D++ECE+ C+ +C N+PG+
Sbjct: 53 ADCDP---NTQAS----CECPEGY----ILDDGFICTDIDECENGGF--CSGVCHNLPGT 99
Query: 304 Y 304
+
Sbjct: 100 F 100
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 29.6 bits (65), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 15 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 74
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 75 NHKNIISLLNV 85
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 29.6 bits (65), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 74 NHKNIISLLNV 84
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 29.6 bits (65), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 38/82 (46%), Gaps = 6/82 (7%)
Query: 410 IGCGGSGLVYKGFLSNKTP------VAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRL 463
+G G G V+ N +P VAVK K +F E +++ + ++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 464 LGCCLETQVPLLVYEFVGNGTL 485
G C + ++V+E++ +G L
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDL 104
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 29.6 bits (65), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIISLLNV 91
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 29.6 bits (65), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 39/76 (51%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+KK ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 14 IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 465 GCCLETQVPLLVYEFV 480
LV+E V
Sbjct: 72 DVIHTENKLYLVFEHV 87
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 29.6 bits (65), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIISLLNV 91
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 29.6 bits (65), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 82 NHKNIISLLNV 92
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 29.6 bits (65), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 15 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 74
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 75 NHKNIISLLNV 85
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 29.6 bits (65), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 20 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 79
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 80 NHKNIISLLNV 90
>pdb|3GIS|X Chain X, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|Y Chain Y, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|Z Chain Z, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
Length = 121
Score = 29.6 bits (65), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 15/61 (24%)
Query: 246 ASCDKPKDNTTTSSGYHCKCNKGYEGNPYLSDG--CHDVNECEDPSLNNCTHICDNIPGS 303
A CD NT S C+C +GY L DG C D++ECE+ C+ +C N+PG+
Sbjct: 53 ADCDP---NTQAS----CECPEGY----ILDDGFICTDIDECENGGF--CSGVCHNLPGT 99
Query: 304 Y 304
+
Sbjct: 100 F 100
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 29.6 bits (65), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 82 NHKNIISLLNV 92
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 29.6 bits (65), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 18/65 (27%), Positives = 33/65 (50%), Gaps = 2/65 (3%)
Query: 429 VAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 486
VAVKK + + + +F E+ ++ + N+V+ G C + L+ EF+ G+L
Sbjct: 45 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 487 EQIHK 491
E + K
Sbjct: 105 EYLQK 109
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 29.6 bits (65), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 29.6 bits (65), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 74 NHKNIISLLNV 84
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 29.6 bits (65), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+ K ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 11 IGEGTYGVVYKA--RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 69 DVIHTENKLYLVFEFL 84
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 29.6 bits (65), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 7/76 (9%)
Query: 410 IGCGGSGLVYKGFLSNKTP---VAVKKSKIVDQTK--MDEFINELVVVSQINRRNVVRLL 464
IG G G+VYK NK VA+ K ++ +T+ I E+ ++ ++N N+V+LL
Sbjct: 10 IGEGTYGVVYKA--RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 465 GCCLETQVPLLVYEFV 480
LV+EF+
Sbjct: 68 DVIHTENKLYLVFEFL 83
>pdb|3J1Q|A Chain A, Structure Of Aav-Dj, A Retargeted Gene Therapy Vector:
Cryo-Electron Microscopy At 4.5a Resolution
Length = 737
Score = 29.6 bits (65), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 17/43 (39%), Positives = 23/43 (53%)
Query: 360 HMKLKEKFFEQNGGSILQQELSKLQGRSSEKAKIFTEEEIKTV 402
H +EKFF Q+G I ++ S+ EK I EEEI+T
Sbjct: 528 HKDDEEKFFPQSGVLIFGKQGSEKTNVDIEKVMITDEEEIRTT 570
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 29.6 bits (65), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 21/49 (42%), Positives = 25/49 (51%), Gaps = 10/49 (20%)
Query: 260 GYHCKCNKGYEG-NPYLSDGCHDVNECEDPSLNNCTHICDNIPG--SYT 305
GY C C+ GYEG N L+ NEC + C H C +PG SYT
Sbjct: 25 GYTCTCSPGYEGSNCELAK-----NECHPERTDGCQHFC--LPGQESYT 66
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 29.6 bits (65), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 5/69 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 26 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 85
Query: 456 NRRNVVRLL 464
N +N++ LL
Sbjct: 86 NHKNIIGLL 94
>pdb|1MZH|A Chain A, Qr15, An Aldolase
pdb|1MZH|B Chain B, Qr15, An Aldolase
Length = 225
Score = 29.6 bits (65), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 41/90 (45%), Gaps = 16/90 (17%)
Query: 164 CCQIEIPRGLKGLEVE-----------ASSFNNHENVSSFNPCTYAFVVDESQ--FHFTP 210
CC I P GL V+ A + N+S+F Y FVV+E + F TP
Sbjct: 57 CCVIGFPLGLNKTSVKVKEAVEAVRDGAQELDIVWNLSAFKSEKYDFVVEELKEIFRETP 116
Query: 211 SYLAVGGIPEKFPVVLDWEI-TTIEICEEA 239
S AV + + P + + EI +EIC EA
Sbjct: 117 S--AVHKVIVETPYLNEEEIKKAVEICIEA 144
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 29.3 bits (64), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 15 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 74
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 75 NHKNIIGLLNV 85
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 29.3 bits (64), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 29.3 bits (64), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIISLLNV 91
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 29.3 bits (64), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 29.3 bits (64), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 29.3 bits (64), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 5/69 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 456 NRRNVVRLL 464
N +N++ LL
Sbjct: 82 NHKNIIGLL 90
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 29.3 bits (64), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 70 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNL 128
Query: 486 FEQIHKK 492
E + +
Sbjct: 129 REYLRAR 135
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 29.3 bits (64), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 29.3 bits (64), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 5/69 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 23 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 82
Query: 456 NRRNVVRLL 464
N +N++ LL
Sbjct: 83 NHKNIIGLL 91
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 29.3 bits (64), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 29.3 bits (64), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 401 TVTNNYADM--IGCGGSGLV---YKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQI 455
TV Y ++ IG G G+V Y L + +QT ELV++ +
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 456 NRRNVVRLLGC 466
N +N++ LL
Sbjct: 81 NHKNIIGLLNV 91
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 29.3 bits (64), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 59 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 117
Query: 486 FEQIHKK 492
E + +
Sbjct: 118 REYLRAR 124
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 29.3 bits (64), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 62 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 486 FEQIHKK 492
E + +
Sbjct: 121 REYLRAR 127
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 28.9 bits (63), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 70 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 486 FEQIHKK 492
E + +
Sbjct: 129 REYLRAR 135
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 70 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 486 FEQIHKK 492
E + +
Sbjct: 129 REYLRAR 135
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 28.9 bits (63), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 57 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 115
Query: 486 FEQIHKK 492
E + +
Sbjct: 116 REYLRAR 122
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 28.9 bits (63), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 39/88 (44%), Gaps = 8/88 (9%)
Query: 410 IGCGGSG----LVYKGFLSNKTPVAVKKSKIVDQTKMDEFINELVVVSQINRRNVVRLLG 465
IG G G V KG + + K + D +D F E+ ++ ++ N++RL
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 466 CCLETQVPLLVYEFVGNGTLFEQ-IHKK 492
+ LV E G LFE+ +HK+
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKR 101
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 28.9 bits (63), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 70 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 486 FEQIHKK 492
E + +
Sbjct: 129 REYLRAR 135
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 28.9 bits (63), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 70 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 486 FEQIHKK 492
E + +
Sbjct: 129 REYLRAR 135
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 28.9 bits (63), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 116 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 486 FEQIHKK 492
E + +
Sbjct: 175 REYLRAR 181
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 28.9 bits (63), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 2/66 (3%)
Query: 429 VAVKKSK-IVDQTKMDEFINELVVVSQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGTLF 486
VAVK K T+ + ++EL V+S + N N+V LLG C L++ E+ G L
Sbjct: 56 VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 487 EQIHKK 492
+ +K
Sbjct: 116 NFLRRK 121
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 28.9 bits (63), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 70 VAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNL 128
Query: 486 FEQIHKK 492
E + +
Sbjct: 129 REYLRAR 135
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 28.9 bits (63), Expect = 7.5, Method: Compositional matrix adjust.
Identities = 19/67 (28%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 429 VAVKKSKIVDQTKMD--EFINELVVVSQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTL 485
VAVK K D T+ D + ++E+ ++ I + +N++ LLG C + ++ E+ G L
Sbjct: 70 VAVKMLKD-DATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 486 FEQIHKK 492
E + +
Sbjct: 129 REYLRAR 135
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 28.5 bits (62), Expect = 8.0, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 35/84 (41%), Gaps = 6/84 (7%)
Query: 410 IGCGGSGLVYKGFLSNKTPVAVKKSKIVDQTKM----DEFINELVVVSQINRRNVVRLLG 465
+G G +G V N+ KIVD + + E+ + +N NVV+ G
Sbjct: 14 LGEGAAGEV--QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 466 CCLETQVPLLVYEFVGNGTLFEQI 489
E + L E+ G LF++I
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRI 95
>pdb|1QCX|A Chain A, Pectin Lyase B
Length = 359
Score = 28.5 bits (62), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 16/86 (18%), Positives = 37/86 (43%)
Query: 36 PFGTRPGCFLNEEFLITCNDTHFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAK 95
P+GT C + C++ PK +T ++ I+++ + +++ K K
Sbjct: 65 PWGTASQCQVAINLHSWCDNYQASAPKVSVTYDKAGILPITVNSNKSIVGQGTKGVIKGK 124
Query: 96 GYSVDSNLPSITLSKFTVSNTENRFV 121
G V S ++ + V++ ++V
Sbjct: 125 GLRVVSGAKNVIIQNIAVTDINPKYV 150
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 28.5 bits (62), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 2/66 (3%)
Query: 429 VAVKKSKI-VDQTKMDEFINELVVVSQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGTLF 486
VAVK K T+ + ++EL V+S + N N+V LLG C L++ E+ G L
Sbjct: 79 VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 487 EQIHKK 492
+ +K
Sbjct: 139 NFLRRK 144
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 28.5 bits (62), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 2/66 (3%)
Query: 429 VAVKKSKI-VDQTKMDEFINELVVVSQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGTLF 486
VAVK K T+ + ++EL V+S + N N+V LLG C L++ E+ G L
Sbjct: 79 VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 487 EQIHKK 492
+ +K
Sbjct: 139 NFLRRK 144
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 28.5 bits (62), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 9/95 (9%)
Query: 410 IGCGGSGLVYKG--FLSNKTP----VAVKKSKI-VDQTKMDEFINELVVVSQINRR-NVV 461
+G G G V + F K+P VAVK K ++ + EL +++ I NVV
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 462 RLLGCCLETQVPLLV-YEFVGNGTLFEQIHKKGNL 495
LLG C + PL+V E+ G L + K +L
Sbjct: 95 NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDL 129
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 28.5 bits (62), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 8/96 (8%)
Query: 405 NYADMIGCGGSGLVYK----GFLSNKTP--VAVKKSK-IVDQTKMDEFINELVVVSQI-N 456
++ +G G G V + G + + VAVK K T+ + ++EL V+S + N
Sbjct: 42 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 457 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQIHKK 492
N+V LLG C L++ E+ G L + +K
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 137
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 28.5 bits (62), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 2/66 (3%)
Query: 429 VAVKKSKI-VDQTKMDEFINELVVVSQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGTLF 486
VAVK K T+ + ++EL V+S + N N+V LLG C L++ E+ G L
Sbjct: 74 VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 133
Query: 487 EQIHKK 492
+ +K
Sbjct: 134 NFLRRK 139
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 28.5 bits (62), Expect = 9.9, Method: Compositional matrix adjust.
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 4/59 (6%)
Query: 435 KIVDQTKM----DEFINELVVVSQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEQI 489
KIVD + + E+ + +N NVV+ G E + L E+ G LF++I
Sbjct: 37 KIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 95
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.137 0.428
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 14,615,429
Number of Sequences: 62578
Number of extensions: 601687
Number of successful extensions: 1806
Number of sequences better than 100.0: 416
Number of HSP's better than 100.0 without gapping: 203
Number of HSP's successfully gapped in prelim test: 213
Number of HSP's that attempted gapping in prelim test: 1567
Number of HSP's gapped (non-prelim): 431
length of query: 499
length of database: 14,973,337
effective HSP length: 103
effective length of query: 396
effective length of database: 8,527,803
effective search space: 3377009988
effective search space used: 3377009988
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 53 (25.0 bits)